|
HS Code |
253964 |
| Product Name | Di-P-Anisoyl-L-Tartaric Acid |
| Cas Number | 94029-39-5 |
| Molecular Formula | C22H20O10 |
| Molecular Weight | 444.39 g/mol |
| Appearance | White to off-white powder |
| Melting Point | Approximately 180-185°C |
| Solubility | Soluble in organic solvents such as methanol and ethanol |
| Optical Activity | Chiral, exhibits optical rotation |
| Purity | Typically ≥98% |
| Usage | Chiral resolving agent, especially for enantiomer separation |
| Storage Conditions | Store in a cool, dry place, away from light |
| Synonyms | Di-p-anisoyl-L-tartaric acid; L-(+)-Di(p-methoxybenzoyl) tartaric acid |
As an accredited Di-P-Anisoyl-L-Tartaric Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Di-P-Anisoyl-L-Tartaric Acid, 25g, is supplied in a sealed amber glass bottle with a screw cap, labeled for laboratory use. |
| Shipping | **Description for Shipping:** Di-P-Anisoyl-L-Tartaric Acid is shipped in tightly sealed containers to protect from moisture and light. It is packed with cushioning material to prevent physical damage during transit. The package must be clearly labeled and accompanied by safety documentation, complying with all relevant chemical transport regulations. Store cool and dry upon arrival. |
| Storage | Di-P-Anisoyl-L-Tartaric Acid should be stored in a tightly sealed container, away from light, moisture, and incompatible substances. Keep it in a cool, dry, and well-ventilated area, preferably at room temperature (15–25°C). Avoid excessive heat and protect it from oxidizing agents. Properly labeled storage is essential to prevent accidental misuse or contamination. |
Applications of Di-P-Anisoyl-L-Tartaric Acid in Industrial ManufacturingDi-P-Anisoyl-L-Tartaric Acid serves a critical function across specialized sectors in chemical, pharmaceutical, and fine materials manufacturing, supporting demanding requirements for selectivity and quality in advanced downstream processes. As a factory-direct producer, we supply this raw material to technical customers seeking precise control in their production lines, with a focus on application-specific integration, compliance adherence, and proven final product outputs. 1. Chiral Intermediate for Pharmaceutical API SynthesisManufacturers use Di-P-Anisoyl-L-Tartaric Acid as a resolving agent in industrial synthesis of chiral active pharmaceutical ingredients. In multi-step enantioselective synthesis, operators add the compound during chiral salt formation or resolution steps, enabling separation of racemic precursors into pure enantiomers. The precise enantiomeric purity achieved with this agent directly influences downstream drug substance quality and regulatory acceptance, especially in large-scale batch production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Optical Purity Standard in Analytical Reference Material ProductionProducers of analytical reference materials employ Di-P-Anisoyl-L-Tartaric Acid to create certified optical purity markers. These specialized reference standards support calibration of HPLC or SFC analytical methods in pharmaceutical and biotech labs. The compound’s application in the synthesis and authentication of reference substances underpins reliable enantiomeric excess quantification critical to regulatory batch release and in-process control environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chiral Additive for Fine Chemical and Agrochemical SynthesisProcess chemists in fine chemical and crop protection industries utilize Di-P-Anisoyl-L-Tartaric Acid as an auxiliary in stereoselective synthetic steps. By enabling selective resolution of chiral intermediates, it allows for the production of enantiomerically pure or enriched compounds required in the next steps of agrochemical or specialty fine chemical formulation. Controlled dosing and phase management are essential to meet both technical performance and regulatory residue limits in the final agricultural products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Enantioselective Stationary Phase Preparation for Chromatography ColumnsProducers of preparative chromatography columns and HPLC stationary phases utilize Di-P-Anisoyl-L-Tartaric Acid for direct grafting onto silica substrates to achieve enantioselective separation capability. The resulting chiral stationary phases enable high-throughput purification and analysis of racemic mixtures across the pharmaceutical, life science, and specialty chemicals markets, meeting demanding customer column performance specifications and lifecycle reproducibility requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Di-P-Anisoyl-L-Tartaric Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
True progress in chiral chemistry only comes when subtle adjustments show real results. Di-P-Anisoyl-L-Tartaric Acid, sometimes designated by its catalog number or abbreviated as D-PATA, reflects years of research and process fine-tuning in our production workshops. We have handled various chiral resolving agents before, and few respond as reliably as this compound. It has achieved a reputation among technical teams in our sector for resolving racemates in both research and large-scale pharmaceutical synthesis.
Most chemists working in asymmetric synthesis look for consistency at scale, and this product answers that need directly. Preparation starts with purified L-Tartaric Acid, reacting it completely with P-Anisoyl chloride, maintaining controlled temperature and humidity throughout the process. Attention to these details blocks unwanted side-products and ensures every batch shows high optical purity. Our in-house chromatographic and polarimetric records stretch back years, showing product that rarely deviates outside 98% enantiomeric excess.
Every run brings its own lessons learned. We have encountered the moisture sensitivity of Di-P-Anisoyl-L-Tartaric Acid firsthand, watching lesser operations suffer losses from storage mistakes. Our team transitioned from simple bagging to inert-atmosphere packing, nitro-sealed drums for larger clients, and smaller fluoropolymer-lined vials for research groups. By focusing on packaging, we cut waste rates by half over a two-year period.
Choosing the right form—dry crystalline powder in our case—lets operators handle the compound without sticky residues that gum up glassware or mechanical feeders. Our teams found that transitioning from low-pressure filtration to vacuum drying shaves hours off post-production time, and more importantly, preserves a crisp crystalline texture that simplifies weighing and dissolving before each synthesis. Whenever someone requests a sample, they comment on the flowability and low static cling, both crucial in automated labs.
Fieldwork and customer visits have shown the breadth of use for this compound. Most researchers see Di-P-Anisoyl-L-Tartaric Acid as a resolving agent, especially for basic amine groups in alkaloid derivatives, or amino alcohols. The performance seldom disappoints; precipitation and phase separation set in at predictable points, and we have demonstrated this behavior for dozens of commonly-used substrates. Those working with alpha-aryl ethylamines notice separation efficiency can outpace tartrate analogs by 10 to 15 percent.
Several API manufacturers we supply use our material for industrial production of chiral intermediates. They cite its solubility in common organic solvents like ethanol, methanol, and dichloromethane, which allows integration into continuous-flow setups. In contrast to Di-Benzoyl Tartaric Acid or Di-p-Toluoyl Tartaric Acid, which sometimes demand higher temperatures or excess solvent volumes, Di-P-Anisoyl-L-Tartaric Acid dissolves readily without added heating belts or lengthy agitation. Scale-up reports show direct solvent recovery and little downstream residue, simplifying both process validation and regulatory documentation.
No amount of marketing can replace the reassurance of reliable analytics. Every batch of Di-P-Anisoyl-L-Tartaric Acid moves through HPLC with chiral stationary phases for optical purity, and we run NMR spectra to confirm structure and absence of residual reactants. Year after year, feedback from contract labs prompts tight QA adjustments; a minor impurity flagged by a client last spring triggered us to refine the wash stage, improving overall purity metrics across the next five production cycles.
Operator training affects outcomes as much as machine calibration. Shifts on our manufacturing line include detailed checklists for reagent addition and endpoint testing. New hires shadow seasoned hands for their first two production runs. We have watched inconsistent crystallization vanish from our processes after implementing these direct handovers. This people-first culture benefits downstream users, who report less unexpected loss or rework.
Many chemical manufacturers offer a spread of tartaric acid derivatives, and for good reason; each variant finds its sweet spot in separating a unique set of racemates. Over several decades, our teams have compared Di-P-Anisoyl-L-Tartaric Acid alongside Di-Benzoyl, Di-p-Toluoyl, and mixed aryl tartaric acids. The methoxy substitution on the phenyl ring in our product tunes both polarity and hydrogen-bonding, translating into tighter and faster crystallization for many nitrogen-containing molecules.
During offsite technical workshops, process chemists describe the challenge of sticking points — times when a particular active ingredient just won’t resolve, even after weeks of method development. Based on real case histories, swapping to Di-P-Anisoyl-L-Tartaric Acid resolves stubborn cases in a single run. Our handling data shows it resists racemization, and because it holds up under slightly basic or neutral conditions, product degradation does not set in as easily as with vanilla tartaric acid.
Scalability makes the difference between lab curiosity and commercial tool. We have watched pilot plants double their order size within a year after switching to our Di-P-Anisoyl-L-Tartaric Acid. From as small as a few grams for early stage medicinal chemistry, up to hundred-kilo drum lots for full pharmaceutical campaigns, we adjust batch volumes while maintaining tight specifications. Sourcing raw L-Tartaric Acid in bulk from longstanding partners keeps cost volatility in check, and our logistics team pre-clears international shipments for customers spanning three continents.
More than a product, it represents a commitment to transparent data, reliable delivery, and the practical tweaks learned from mistakes. Technical teams know delays aren’t just an inconvenience — for multi-ton chemical campaigns, an unexpected impurity or late shipment can block an entire production schedule. Fielding calls from customers chasing a critical batch sharpens focus and prompts new efficiencies. We’ve built redundancy into filtration and drying, and run split-batch analytics to catch deviations early.
Through years on the shop floor, practical realities shape priorities. Any tartaric acid derivative, Di-P-Anisoyl-L-Tartaric Acid included, generates some process solvent waste and solid residues. Recovering every kilogram of spent solvent isn’t just a cost issue; regulatory and local requirements for chemical industries ramp up environmental scrutiny every year. Starting five years ago, we designed reclaim loops for solvents, trimming waste by up to 30%. Aqueous washes, previously sent to general waste, now move through neutralization pits and are sampled before approved disposal. Periodic audits from both client teams and regulatory bodies keep focus high on emissions and safe handling protocols.
Worker safety stands as the leading concern each production run. Our team wears full PPE, rotates away from repetitive steps, and takes part in quarterly safety reviews. Solvent vapor monitoring and fire suppression systems build on real lessons from incidents decades past. By building a safety culture into daily practices, everyone on the floor looks out for the small things — from chemical splash risks to ergonomic handling. Smaller packs for academic or startup customers, designed for ease of use, reduce accidental exposure and let new users ramp up safely.
The wave of new drug candidates and specialty materials entering the market each year places ever more pressure on reliable chiral resolution. Consistent access to high-purity Di-P-Anisoyl-L-Tartaric Acid allows research teams to step past routine separation and delve into more complex and valuable molecular scaffolds. We have seen our product appear in academic publications and patents, always backed by clear characterization data and reproducible methods.
Continuous improvement means listening to researchers experimenting with green chemistry alternatives. We collaborate with academic labs to test new solvent systems — water-miscible organics, recyclable ionic liquids, supercritical fluids — and adjust our support to help unlock process innovations. Staff chemists at our site document results and share anonymized findings with partners, helping advance sustainable chemistry across company lines.
It’s easy from the outside to treat compounds as simple catalog items, but the reality in the production facility involves dozens of small adjustments, missed batches, and troubleshooting sessions. Di-P-Anisoyl-L-Tartaric Acid production relies on stable sourcing for both raw materials and packaging. Once, late arrival of high-purity anisoyl chloride forced a temporary halt; talking with supply partners revealed a bottleneck in their QC program. We switched procurement focus to more transparent vendors with digital lot tracking, and delivery slipped back to regularity in the next cycle.
Team-based problem solving handles batch-to-batch troubleshooting. A sudden drop in crystallization yield prompted our group to recheck solvent ratios and investigate for trace impurities in incoming tartaric acid. The shift lead caught the issue in one afternoon, and immediate process adjustments restored yield. The same product that leaves our site carries this accumulated experience and countless reality checks behind each drum or bottle.
Success stories only mean as much as the challenges overcome. Researchers and process chemists call in to discuss oddities—maybe a slower filtration than usual, or extra haze in a solution. Each discussion becomes a record for internal improvement. Feedback from end users pushed us to test alternate filtration media, and swapping a single supplier halved clogging issues in back-to-back campaigns. Continuous dialogue with customers and technical sales teams closes the circle that links lab process to product properties on the user side.
Scale-up chemists emphasize their need for traceability and consistency. We built out comprehensive batch record systems, linking every production step and analytic checkpoint to each delivery. When a customer requests a historic CoA for a regulatory filing, there is never a scramble; archived records stretch back a decade. In the rare event of a deviation, immediate follow-up and open correction cement long-term trust. For new customers starting with just a few grams, our technical team walks through safe handling and offers real examples from similar syntheses.
Chiral resolution agents factor into regulatory filings, particularly in pharmaceutical intermediates and APIs. Not every supplier tracks country-specific impurity profiles or packaging mandates, but years of shipments taught us the cost of missed details. Flagging restricted solvents, or updating product documentation to comply with evolving standards, becomes a daily reality. We work directly with regulatory affairs partners to update test panels, so each consignment matches specific client or governmental guidelines.
Market dynamics shift yearly, and expanding application areas—flavor chemistry, fine chemicals, even new fields like battery materials—prompt us to reassess production scheduling. Building flexibility into operational planning keeps core customers supplied, even as we take on new R&D runs for development partners. No two production cycles run the exact same, and our teams respond not just to numbers but to the real urgency underlying every order.
Experience in manufacturing teaches that no chemical exists in isolation from those who depend on it and those who produce it. Di-P-Anisoyl-L-Tartaric Acid stands as both a technical tool and a testament to cumulative learning. Whether separating a challenging racemate at the research bench or delivering pallet-loads for pharmaceutical synthesis, all parties benefit from reliable performance, honest communication, and thorough understanding of product behavior in real-world conditions.
Direct connections with chemists in the field reinforce the value of transparency and flexibility every day. Every analytical result, delivery deadline, and technical question is met with the humility that only hands-on work can teach. The ongoing evolution of Di-P-Anisoyl-L-Tartaric Acid, shaped by each batch, every critique, and every partnership, speaks to a future built not just on molecules, but on mutual trust and practical know-how.